Notably, kidney and cardiovascular benefits of finerenone were apparent even in combination with SGLT2i and GLP1-RA use in secondary analyses of the FIDELIO-DKD and FIGARO-DKD trials [71, 72]
Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease
Middle age is where the conditions these drugs treat, obesity and type 2 diabetes, become common, and where most people still have private insurance or the income to cover a drug that has listed at more than $1,000 a month
By activating GLP-1 receptors, semaglutide suppresses appetite, reduces hunger cravings, and lowers calorie intake